D-0257-2015 Class III Terminated

Recalled by Zydus Pharmaceuticals USA Inc — Pennington, NJ

FDA drug recall D-0257-2015 was initiated by Zydus Pharmaceuticals USA Inc on Oct 1, 2014 and is designated Class III. Reason for recall: Discoloration: Brown spots were noted embedded in Amlodipine Besylate Tablets, 10 mg, Lot # MP4344. The recall status is terminated (terminated Feb 26, 2016). Affected quantity: 15,144 bottles.

Recall details

Product Type
Drugs
Report Date
Dec 3, 2014
Initiation Date
Oct 1, 2014
Termination Date
Feb 26, 2016
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
15,144 bottles

Product description

Amlodipine Besylate Tablets, USP 10 mg, Rx Only, 90 Tablets per bottle, Manufactured by: Cadila Healthcare Ltd. Ahmedabad, India, Distributed by: Zydus Pharmaceuticals USA Inc., Pennington, NJ 08534, NDC 68382-123-16

Reason for recall

Discoloration: Brown spots were noted embedded in Amlodipine Besylate Tablets, 10 mg, Lot # MP4344.

Distribution pattern

Nationwide

Code information

Lot #: MP4344, Exp 04/2016

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0257-2015
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0257-2015. Report a data issue: hello@regdatalab.com.